The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis
Mini abstract This meta-analysis demonstrated that a greater prevalence of delayed union
and nonunion and a longer time to fracture healing in the group that did not receive TPTD …
and nonunion and a longer time to fracture healing in the group that did not receive TPTD …
Are secondary effects of bisphosphonates on the vascular system of bone contributing to increased risk for atypical femoral fractures in osteoporosis?
DA Hart - BioEssays, 2023 - Wiley Online Library
Osteoporosis (OP) is a bone disease which affects a number of post‐menopausal females
and puts many at risk for fractures. A large number of patients are taking bisphosphonates …
and puts many at risk for fractures. A large number of patients are taking bisphosphonates …
Atypical femoral fracture in hypophosphatasia: a systematic review
N Charoenngam, J Thongpiya… - International Journal …, 2023 - Wiley Online Library
Objective. To summarize the characteristics of all reported patients with hypophosphatasia
(HPP) who sustained atypical femoral fracture (AFF) and identify all available evidence to …
(HPP) who sustained atypical femoral fracture (AFF) and identify all available evidence to …
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients
E Ng, C Ashkar, E Seeman, HG Schneider… - Osteoporosis …, 2023 - Springer
Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an
osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture …
osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture …
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture
Abstract Objective Atypical femur fractures (AFFs) are rare fragility fractures originating at the
lateral cortex of the femur, affecting the subtrochanteric or diaphyseal area of thebone with a …
lateral cortex of the femur, affecting the subtrochanteric or diaphyseal area of thebone with a …
When and how to stop denosumab therapy in a patient with osteoporosis
EL Goulden, RK Crowley - Clinical Endocrinology, 2023 - Wiley Online Library
Denosumab is a human monoclonal antibody that competitively inhibits the receptor
activator of nuclear factor kappa B ligand which regulates osteoclast activity. It is an effective …
activator of nuclear factor kappa B ligand which regulates osteoclast activity. It is an effective …
Verlaufsdiagnostik des Knochenstoffwechsels unter verschiedenen Therapieformen
B Obermayer-Pietsch, I Fößl - Osteologie, 2023 - thieme-connect.com
Osteoporose ist per se eine chronische Erkrankung, daher sind neben
nichtpharmakologischen Interventionen (z. B. hinsichtlich Ernährung und Bewegung) vor …
nichtpharmakologischen Interventionen (z. B. hinsichtlich Ernährung und Bewegung) vor …
[HTML][HTML] Persistent Bilateral Atypical Femoral Fractures in an Antiresorptive-Naïve Singaporean Chinese Patient with Graves' Disease
KS Choo, LM Dacay, LU Gani - Journal of the ASEAN Federation …, 2023 - ncbi.nlm.nih.gov
Atypical femoral fractures (AFFs) are rare adverse effects of bisphosphonate therapy. We
report an unusual case of bilateral diaphyseal AFFs in an antiresorptive-naïve Singaporean …
report an unusual case of bilateral diaphyseal AFFs in an antiresorptive-naïve Singaporean …
Estudio de las células mesenquimales en la osteoporosis
L López Delgado - 2023 - repositorio.unican.es
El hueso es un tejido que se encuentra en un constante proceso de remodelado debido a la
acción de los osteoblastos, encargados de la formación ósea, y de los osteoclastos …
acción de los osteoblastos, encargados de la formación ósea, y de los osteoclastos …